Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Li, P. K. T.
Right arrow Articles by Lai, F. M.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, P. K. T.
Right arrow Articles by Lai, F. M.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 64-69
© 2002 European Renal Association-European Dialysis and Transplant Association

Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives

Philip Kam Tao Li1,, Kelvin Kai Leung Ho1, Cheuk Chun Szeto1, LyMee Yu1 and Fernand Mac-Moune Lai2

1 Departments of Medicine and Therapeutics and 2 Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, People’s Republic of China

Background. IgA nephropathy is the most common primary glomerulonephritis in the world. Up to 30% of patients can progress to end-stage renal disease (ESRD) in 10 years.

Methods. We studied 168 Chinese patients with IgA nephropathy followed for an average of 7.4 years in our hospital and tried to identify the clinical and pathological data that were associated with the prognosis of the disease. Clinical features at the time of renal biopsy were reviewed. Severity of histological involvement was scored semi-quantitatively as grade 1–3.

Results. There was a female preponderance in our cohort of patients (male:female ratio 1:1.5). The average age at biopsy was 32.9±10.0 years. Forty-seven of the 168 patients (28.0%) were hypertensive and 47 of 136 patients (34.6%) had a family history of hypertension. A high histological grade of IgA nephropathy was associated with hypertension at presentation, family history of hypertension, a higher serum creatinine, total cholesterol and 24-h urine protein excretion, and a lower serum albumin level. During the follow-up period, four patients died and another 24 progressed to ESRD. The renal survival was 92.0% at 1 year, 87.5% at 5 years and 81.8% at 10 years. With univariate analysis, hypertension at presentation, family history of hypertension, renal impairment at presentation (plasma creatinine >120 µmol/l), high cholesterol, proteinuria >1 g/day and high histological grading were associated with poor prognosis. With multivariate analysis, hypertension at presentation, family history of hypertension, renal impairment at presentation, proteinuria >1 g/day and histological grading were independent predictors of renal survival. The relative risks of renal failure for patients were 9.60 (95% confidence interval 4.02–22.92) with hypertension, 1.56 (1.16–2.02) with a family history of hypertension, 15.38 (6.40–36.93) with renal impairment and 5.93 (3.07–11.46) with every increase of one histological grade. Male patients did not show a more adverse outcome compared with females.

Conclusions. Our results suggest that renal biopsy remains useful, even in clinically trivial disease, because of its distinct value in prognosis and risk stratification. The long-term prognosis of IgA nephropathy in Chinese patients is guarded. The prognostic importance of family history of hypertension has not been widely recognized and requires further study.

Keywords: Chinese; IgA nephropathy; renal failure

Correspondence and offprint requests to: Dr Philip K. T. Li, Department of Medicine, Prince of Wales Hospital, Shatin, Hong Kong, People's Republic of China. Email: philipli{at}cuhk.edu.hk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Espinosa, R. Ortega, J. M. Gomez-Carrasco, F. Lopez-Rubio, M. Lopez-Andreu, M. O. Lopez-Oliva, and P. Aljama
Mesangial C4d deposition: a new prognostic factor in IgA nephropathy
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Kaartinen, J. Syrjanen, I. Porsti, M. Hurme, A. Harmoinen, A. Pasternack, H. Huhtala, and J. Mustonen
Inflammatory markers and the progression of IgA glomerulonephritis
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1285 - 1290.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. N. Reich, S. Troyanov, J. W. Scholey, D. C. Cattran, and for the Toronto Glomerulonephritis Registry
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3177 - 3183.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. H. Jafar, C. H. Schmid, P. C. Stark, R. Toto, G. Remuzzi, P. Ruggenenti, C. Marcantoni, G. Becker, S. Shahinfar, P. E. de Jong, et al.
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2047 - 2053.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.